Patents Assigned to Bioenergy, Inc.
-
Patent number: 9034793Abstract: The present invention relates to methods and compositions for supplementing the soil/diet of plants in order to enhance plant growth, yield, hardening, as well as the recovery of plants which undergo transplantation. The present invention provides ribose and other pentose sugars and their derivatives, alone or in combination with other carbohydrates, electrolytes, minerals, enzymes, micronutrients, macronutrients, or other ingredients to enhance plant growth, yield, hardening, and aid in the recovery during and following transplantation.Type: GrantFiled: July 16, 2013Date of Patent: May 19, 2015Assignee: Bioenergy, Inc.Inventors: John G Seifert, Linda M Shecterle
-
Patent number: 8835396Abstract: This invention discloses a method and compositions for treatment or prevention of pulmonary hypertension in a mammal. Representative mammals include humans and horses. The invention further relates to supplements especially beneficial in preventing or stopping the progression of pulmonary hypertension. The supplements include ribose and folate. Additional nutrients include omega-3 fatty acids and gamma-linolenic acid.Type: GrantFiled: December 15, 2006Date of Patent: September 16, 2014Assignee: Bioenergy, Inc.Inventors: George Verlaan, John A. St. Cyr
-
Patent number: 8741854Abstract: Feed supplements for poultry raised using a rapid growth regimen are disclosed herein. The supplements include D-ribose in an amount effective to improve the resistance to cardiomyopathy in the poultry. Methods for feeding poultry are also disclosed herein.Type: GrantFiled: February 19, 2010Date of Patent: June 3, 2014Assignee: Bioenergy, Inc.Inventors: John A. St. Cyr, Raj Khankari, Paul B. Addis
-
Patent number: 8486859Abstract: The present invention relates to methods and compositions for supplementing the soil/diet of plants in order to enhance plant growth, yield, hardening, as well as the recovery of plants which undergo transplantation. The present invention provides ribose and other pentose sugars and their derivatives, alone or in combination with other carbohydrates, electrolytes, minerals, enzymes, micronutrients, macronutrients, or other ingredients to enhance plant growth, yield, hardening, and aid in the recovery during and following transplantation.Type: GrantFiled: May 15, 2002Date of Patent: July 16, 2013Assignee: Bioenergy, Inc.Inventors: John G. Seifert, Linda M. Shecterle
-
Publication number: 20120264701Abstract: Low doses of D-ribose raise the level of fitness and lower the perception of fatigue in baby boomers aged 45-65 who perceive themselves as fatigued. The doses range from 0.100 grams to 3.0 grams, bid, for a total of 0.200 to 6.0 grams daily. Objective measures of cardiopulmonary parameters confirm the improvement of fitness and questionnaires confirm that quality of life and mental states are improved with D-ribose administration.Type: ApplicationFiled: April 11, 2012Publication date: October 18, 2012Applicant: Bioenergy, Inc.Inventors: John A. St. Cyr, Dean J. MacCarter
-
Patent number: 8101581Abstract: D-ribose, given in doses of five to 15 grams daily, reduces or prevents the occurrence of atrial fibrillation in persons experiencing atrial fibrillation.Type: GrantFiled: January 23, 2008Date of Patent: January 24, 2012Assignee: Bioenergy, Inc.Inventor: James D. Herrick
-
Publication number: 20100189785Abstract: Low doses of D-ribose raise the level of fitness and lower the perception of fatigue in baby boomers aged 45-65 who perceive themselves as fatigued. The doses range from 0.100 grams to 3.0 grams, bid, for a total of 0.200 to 6.0 grams daily. Objective measures of cardiopulmonary parameters confirm the improvement of fitness and questionnaires confirm that quality of life and mental states are improved with D-ribose administration.Type: ApplicationFiled: August 20, 2009Publication date: July 29, 2010Applicant: Bioenergy, Inc.Inventors: John A. St. Cyr, Dean J. MacCarter
-
Publication number: 20100009924Abstract: The present invention relates to methods for supplementing the diet of subjects suffering from cardiovascular disease. D-Ribose is given long term alone or in combination with vasodilators in order to improve or maintain the diastolic or systolic function of the subjects.Type: ApplicationFiled: June 26, 2009Publication date: January 14, 2010Applicant: Bioenergy, Inc.Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
-
Patent number: 7553817Abstract: The present invention relates to compositions for supplementing the diet of subjects suffering from cardiovascular or peripheral vascular disease or those at risk for such conditions. Ribose is given alone or in combination with one or a combination of vasodilators, nutrients and vitamins. Preferred vitamins include Vitamins C, B6, B12 and folic acid. Preferred nutrients include glutamine and glucose.Type: GrantFiled: October 23, 2003Date of Patent: June 30, 2009Assignee: Bioenergy, Inc.Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
-
Patent number: 7094762Abstract: The present invention relates to methods and compositions comprising ribose and maleate for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially useful for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in fibromyalgia syndrome.Type: GrantFiled: December 27, 2003Date of Patent: August 22, 2006Assignee: Bioenergy, Inc.Inventors: Terri L. Butler, Dean J. MacCarter, Daryl K. MacCarter
-
Patent number: 6790603Abstract: Blood platelets stored in an isotonic, balanced salt solution under standard storage conditions retain function after ten days of storage when micormolar or nanomolar amounts of pentose are added to the solution. The preferred pentoses are D-Ribose, xylulose-5-phosphate and the pentose-related alcohol xylitol.Type: GrantFiled: December 21, 2000Date of Patent: September 14, 2004Assignee: Bioenergy, Inc.Inventors: Daniel G. Ericson, John St. Cyr
-
Patent number: 6703370Abstract: The present invention relates to methods and compositions comprising ribose for the treatment of fibromyalgia syndrome. The methods and compositions of the invention are especially suitable for oral administration and are useful for alleviating the symptoms of pain, fatigue, and irritable bowel syndrome in fibromyalgia syndrome.Type: GrantFiled: October 26, 2000Date of Patent: March 9, 2004Assignee: Bioenergy, Inc.Inventors: Terri L. Butler, Dean J. MacCarter, Daryl K. MacCarter
-
Patent number: 6663859Abstract: D-Ribose and methods for using D-Ribose are provided for enhancing the immune response in mammals. Those with a less than optimal immune response will benefit from oral or parenteral administration of D-Ribose. Methods are also provided for the enhancement of the immune response in isolated leukocytes. Leukocytes are cultured ex vivo in the presence of D-Ribose and transfused into a patient in need of leukocyte augmentation.Type: GrantFiled: January 8, 2001Date of Patent: December 16, 2003Assignees: Bioenergy, Inc., University of FloridaInventors: Susan S. Percival, Robin J. Henken, John St. Cyr, Clarence A. Johnson, Terri L. Butler
-
Patent number: 6511964Abstract: Persons encountering high altitudes without being acclimatized can prevent or alleviate the symptoms of acute mountain sickness by administration of ribose one to four times a days, beginning immediately on encountering high altitudes and continuing for at least five days.Type: GrantFiled: March 29, 2001Date of Patent: January 28, 2003Assignee: Bioenergy, Inc.Inventors: Terri L. Butler, John St. Cyr, Clarence A. Johnson
-
Patent number: 6218366Abstract: The administration of ribose raises the hypoxic threshold of mammals experiencing a hypoxic condition. The presence of an effective amount of ribose in the tissue of a mammal increases the tolerance to hypoxia and decreases the symptoms of hypoxia in mammals experiencing chronic hypoxia due to cardiovascular disease or peripheral vascular disease. Such mammals are additionally benefited by administration of ribose and a vasodilator or an isotropic agent. Mammals experiencing transient hypoxia from high altitude, anesthesia or exercise are also benefited.Type: GrantFiled: September 24, 1999Date of Patent: April 17, 2001Assignee: Bioenergy, Inc.Inventors: John St. Cyr, Clarence A. Johnson, Dean J. MacCarter, Stephen G. Sawada
-
Patent number: 6159942Abstract: Precursors of adenosine triphosphate are administered orally to increase intracellular ATP concentration as dietary supplements or for treatment of reduced energy availability resulting from strenuous physical activity, illness or trauma. Pentose sugars are administered individually, mixed into dry food or in solution. The preferred pentose is D-ribose, singly or combined with creatine, pyruvate, L-carnitine and/or vasodilating agents. Additionally, magnesium, electrolytes, fatty acids and hexose sugars can be used. The compositions and methods of this invention are especially beneficial to mammals having reduced energy availability or high energy demand.Type: GrantFiled: April 12, 1999Date of Patent: December 12, 2000Assignee: Bioenergy, Inc.Inventors: John St. Cyr, Clarence A. Johnson
-
Patent number: 6159943Abstract: Ribose administered before exercise reduces or prevents exercise-induced muscle cramping and soreness. Ribose taken both before and immediately after exercise further reduces or prevents exercise-induced muscle cramping and soreness.Type: GrantFiled: September 24, 1999Date of Patent: December 12, 2000Assignee: Bioenergy, Inc.Inventors: Terri Butler, John St. Cyr